91 related articles for article (PubMed ID: 19597041)
1. Validating the Framingham Hypertension Risk Score: results from the Whitehall II study.
Kivimäki M; Batty GD; Singh-Manoux A; Ferrie JE; Tabak AG; Jokela M; Marmot MG; Smith GD; Shipley MJ
Hypertension; 2009 Sep; 54(3):496-501. PubMed ID: 19597041
[TBL] [Abstract][Full Text] [Related]
2. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.
Talmud PJ; Hingorani AD; Cooper JA; Marmot MG; Brunner EJ; Kumari M; Kivimäki M; Humphries SE
BMJ; 2010 Jan; 340():b4838. PubMed ID: 20075150
[TBL] [Abstract][Full Text] [Related]
3. Framingham risk score for prediction of cardiovascular diseases: a population-based study from southern Europe.
Artigao-Rodenas LM; Carbayo-Herencia JA; Divisón-Garrote JA; Gil-Guillén VF; Massó-Orozco J; Simarro-Rueda M; Molina-Escribano F; Sanchis C; Carrión-Valero L; López de Coca E; Caldevilla D; López-Abril J; Carratalá-Munuera C; Lopez-Pineda A;
PLoS One; 2013; 8(9):e73529. PubMed ID: 24039972
[TBL] [Abstract][Full Text] [Related]
4. Prediction of incident hypertension risk in women with currently normal blood pressure.
Paynter NP; Cook NR; Everett BM; Sesso HD; Buring JE; Ridker PM
Am J Med; 2009 May; 122(5):464-71. PubMed ID: 19375556
[TBL] [Abstract][Full Text] [Related]
5. A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT).
Rosella LC; Manuel DG; Burchill C; Stukel TA;
J Epidemiol Community Health; 2011 Jul; 65(7):613-20. PubMed ID: 20515896
[TBL] [Abstract][Full Text] [Related]
6. Risk models to predict hypertension: a systematic review.
Echouffo-Tcheugui JB; Batty GD; Kivimäki M; Kengne AP
PLoS One; 2013; 8(7):e67370. PubMed ID: 23861760
[TBL] [Abstract][Full Text] [Related]
7. The Impact of the Older Person's Grant Expansion on Hypertension Among Older Men in Rural South Africa: Findings From the HAALSI Cohort.
Chang H; Jock J; Rosenberg MS; Li C; Cho TC; Gaziano TA; Lisabeth L; Kobayashi LC
Innov Aging; 2024; 8(4):igae010. PubMed ID: 38628827
[TBL] [Abstract][Full Text] [Related]
8. Development of hypertension models for lung cancer screening cohorts using clinical and thoracic aorta imaging factors.
Yang J; Yu J; Wang Y; Liao M; Ji Y; Li X; Wang X; Chen J; Qi B; Yang F
Sci Rep; 2024 Mar; 14(1):6862. PubMed ID: 38514739
[TBL] [Abstract][Full Text] [Related]
9. Prognostic risk models for incident hypertension: A PRISMA systematic review and meta-analysis.
Schjerven FE; Lindseth F; Steinsland I
PLoS One; 2024; 19(3):e0294148. PubMed ID: 38466745
[TBL] [Abstract][Full Text] [Related]
10. Development of risk models of incident hypertension using machine learning on the HUNT study data.
Schjerven FE; Ingeström EML; Steinsland I; Lindseth F
Sci Rep; 2024 Mar; 14(1):5609. PubMed ID: 38454041
[TBL] [Abstract][Full Text] [Related]
11. The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging.
Ungvari Z; Tabák AG; Adany R; Purebl G; Kaposvári C; Fazekas-Pongor V; Csípő T; Szarvas Z; Horváth K; Mukli P; Balog P; Bodizs R; Ujma P; Stauder A; Belsky DW; Kovács I; Yabluchanskiy A; Maier AB; Moizs M; Östlin P; Yon Y; Varga P; Vokó Z; Papp M; Takács I; Vásárhelyi B; Torzsa P; Ferdinandy P; Csiszar A; Benyó Z; Szabó AJ; Dörnyei G; Kivimäki M; Kellermayer M; Merkely B
Geroscience; 2024 Feb; 46(1):191-218. PubMed ID: 38060158
[TBL] [Abstract][Full Text] [Related]
12. Body mass index, neck circumference, and hypertension: a prospective cohort study.
Ren TJ; Zhang K; Li WJ; Ren ST; Huang YZ; Yang N; Wu SL; Li YM
Front Cardiovasc Med; 2023; 10():1269328. PubMed ID: 37849941
[TBL] [Abstract][Full Text] [Related]
13. Risk Assessment Score and Chi-Square Automatic Interaction Detection Algorithm for Hypertension Among Africans: Models From the SIREN Study.
Asowata OJ; Okekunle AP; Akpa OM; Fakunle AG; Akinyemi JO; Komolafe MA; Sarfo FS; Akpalu AK; Obiako R; Wahab KW; Osaigbovo Osawaru GO; Owolabi LF; Jenkins CM; Calys-Tagoe BNL; Arulogun OS; Ogbole GI; Ogah OS; Lambert AT; Ibinaiye PO; Adebayo PB; Singh A; Adeniyi SA; Mensah YB; Laryea RY; Balogun O; Chukwuonye II; Akinyemi RO; Ovbiagele B; Owolabi MO
Hypertension; 2023 Dec; 80(12):2581-2590. PubMed ID: 37830199
[TBL] [Abstract][Full Text] [Related]
14. The Use of Machine Learning for the Care of Hypertension and Heart Failure.
Cai A; Zhu Y; Clarkson SA; Feng Y
JACC Asia; 2021 Sep; 1(2):162-172. PubMed ID: 36338169
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of prediction models for hypertension risks: A cross-sectional study based on 4,287,407 participants.
Ji W; Zhang Y; Cheng Y; Wang Y; Zhou Y
Front Cardiovasc Med; 2022; 9():928948. PubMed ID: 36225955
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Post-critical Illness Cardiovascular Disease.
Owen A; Patel JM; Parekh D; Bangash MN
Front Cardiovasc Med; 2022; 9():854421. PubMed ID: 35911546
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a hypertension risk prediction model and construction of a risk score in a Canadian population.
Chowdhury MZI; Leung AA; Sikdar KC; O'Beirne M; Quan H; Turin TC
Sci Rep; 2022 Jul; 12(1):12780. PubMed ID: 35896590
[TBL] [Abstract][Full Text] [Related]
18. Prediction of hypertension using traditional regression and machine learning models: A systematic review and meta-analysis.
Chowdhury MZI; Naeem I; Quan H; Leung AA; Sikdar KC; O'Beirne M; Turin TC
PLoS One; 2022; 17(4):e0266334. PubMed ID: 35390039
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of hypertension prediction models: The Korean Genome and Epidemiology Study_Cardiovascular Disease Association Study (KoGES_CAVAS).
Namgung HK; Woo HW; Shin J; Shin MH; Koh SB; Kim HC; Kim YM; Kim MK
J Hum Hypertens; 2023 Mar; 37(3):205-212. PubMed ID: 35181762
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Decision Rules Models to Stratify Coronary Artery Disease, Diabetes, and Hypertension Risk in Preventive Care: Cohort Study of Returning UK Biobank Participants.
Castela Forte J; Folkertsma P; Gannamani R; Kumaraswamy S; Mount S; de Koning TJ; van Dam S; Wolffenbuttel BHR
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
